- Home
- NTRB vs FGNX Comparison
NTRB vs FGNX Comparison
Compare NTRB & FGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NTRB | FGNX |
|---|---|---|
| Founded | 2016 | 1932 |
| Country | United States | United States |
| Employees | 3 | 15 |
| Industry | Industrial Specialties | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.2M | 44.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NTRB | FGNX |
|---|---|---|
| Price | $3.60 | $6.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | 7.8K | ★ 98.1K |
| Earning Date | 05-29-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $30.17 | $650.31 |
| Revenue Next Year | $3,394.36 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.42 | $1.59 |
| 52 Week High | $11.68 | $18.42 |
Technical Indicators
Market Signals| Indicator | NTRB | FGNX |
|---|---|---|
| Relative Strength Index (RSI) | 40.62 | 52.42 |
| Support Level | $3.51 | $6.52 |
| Resistance Level | $4.24 | $7.17 |
| Average True Range (ATR) | 0.19 | 0.50 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 13.05 | 63.89 |
Price Performance
Historical ComparisonAbout NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About FGNX Fundamental Global Inc.
FG Nexus Inc operates through two primary segments: Digital Assets and Merchant Banking, with Digital Assets contributing the majority of revenue. The Company functions as a digital asset treasury, mainly holding Ethereum (ETH) and exploring opportunities in the tokenization of real-world assets, leveraging ETH as the foundation for digital finance, stablecoins, DeFi, and tokenized assets. The Merchant Banking segment offers strategic, administrative, and regulatory support to newly formed SPACs through the Company's SPAC platform.